在罕见恶性瘤中发现生物标志物:开发RDEB-cSCC的miRNA签名

Roland Zauner1, Monika Wimmer1, Sabine Atzmueller2

  • 1EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology & Allergology, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.

Cancers
|July 14, 2023
PubMed
概括

机器学习模型使用miRNA签名准确地检测了衰退性缩性表皮溶解牛 (RDEB) 患者的罕见皮肤状细胞癌 (cSCC). 这种方法利用公共数据来改善早期瘤检测和临床可行性.